Home  |  Search:

Nature Magazine Features FreeMind

Read the piece in Nature on Funding Finders and FreeMind's major contribution and impact in the field:  Full Article - PDF  

Non-Dilutive Life Science Networking and Group Discussion

The "Life Science Funding Group" on Meetup is holding an event in Cambridge, MA on Friday June 22, 2012.  FreeMind's Vice President, Ayal Ronen, will host a group discussion and networking event to summarize the BIO week and discuss various non-dilutive sources of funding available to support diverse R&D efforts. For moredetails and to RSVP, please click here

Ram May-Ron's Presentation at National Academies of Science UIDP: Non-Dilutive Funding of Academia-Industry R&D Collaborations

FreeMind's Managing Partner's presentation at the National Academies of Science UIDP conference discussing Industry Academic collaborations in research and development and funding to such collaborations through non-dilutive funding sources.

FreeMind Group's Bio-Defense and Infectious Diseases Funding Opportunities Webinar

A webinar by Ayal Ronen, M.Sc. - Senior Director Marketing and Sales at Freemind group. The webinar discusses recent non-dilutive funding opportunities supporting biodefense and infectious diseases research and development efforts.

Turning Grants & Contracts into A Strategic Source of Funding

Non dilutive R&D funding – mainly multibillion programs of Federal agencies – has become a major player in the life science finance industry. Today more than ever, NIH, DOD, NSF, CDC and dozens of other agencies, both federal and private, support biological and medical preclinical and clinical activities in all fields and scopes of research and development.

From Basic Research to Clinical Trials

Non dilutive funding is available for every conceivable kind of research or development effort, whether it is an academic or industry project. Government agencies, as well as state organizations and private foundations, release daily hundreds of different solicitations covering topics that are of interest to public health and medical and life science research.

Large Scale Funding Opportunities

Over the last decade, many academic institutions established specialized centers that articulate their expertise in specific fields. These centers have the advantage of highly specialized human and physical resources. By virtue of their specifically defined purpose, they bring together the top experts in the field, working in proximity to each other for mutually beneficial and especially productive research.  

Leveraging the Work of Academic Centers

Over the last decade, many academic institutions established specialized centers that articulate their expertise in specific fields. These centers have the advantage of highly specialized human and physical resources. By virtue of their specifically defined purpose, they bring together the top experts in the field, working in proximity to each other for mutually beneficial and especially productive research.

The Special Needs of the Bio Defense Community

Over the past decade, the United States government has allocated nearly $55 billion on preparing the nation against biological threats. The Obama administration has maintained that momentum with a total biodefense budget of $6.05 billion for FY2010, going primarily to the NIH and DOD. Additional civilian biodefense funds have been budgeted to the DHS, USDA, EPA, NSF and Department of State.

SBIR/STTR & Beyond

One of the most common misperceptions relating to non-dilutive funding for life science R&D is that the SBIR/STTR program is the main and even only funding resource available for the life science industry.